INTENSITY THERAPEUTICS, INC.
INTSCIK 0001567264 · Biological Products, (No Diagnostic Substances) · Nasdaq
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$10.99M
+28.7% YoY
Q1 May 2026
EPS Diluted (TTM)
−$6.66
+70.7% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$10.25M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
2.7M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.